I listened to a presentation the Edwards CEO made September 7 and the questions around that valve, like that article also mentions, were around the underwhelming results it had with respect to patients' quality of life and questions clinicians had about those results. With that and the halted new Sapien trial due to problems with the delivery system, Edwards has had some issues recently.
In that Sept call, the CEO made some cryptic comments about new investments they have made both internally and externally that haven't been made public yet. I don't see how that could be us but they are actively investing.
Update on Edwards, page-11
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.51 |
Change
-0.490(3.50%) |
Mkt cap ! $285.5M | |||
| Open | High | Low | Value | Volume |
| $14.05 | $14.05 | $13.40 | $234.3K | 17.15K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $13.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.70 | 614 | 1 |
View Market Depth
| Last trade - 15.59pm 08/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |